These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22579304)

  • 1. N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia.
    Shungu DC
    Biol Psychiatry; 2012 Jun; 71(11):937-8. PubMed ID: 22579304
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development.
    das Neves Duarte JM; Kulak A; Gholam-Razaee MM; Cuenod M; Gruetter R; Do KQ
    Biol Psychiatry; 2012 Jun; 71(11):1006-14. PubMed ID: 21945305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of postresuscitation N-acetylcysteine on cerebral free radical production and perfusion during reoxygenation of hypoxic newborn piglets.
    Lee TF; Tymafichuk CN; Bigam DL; Cheung PY
    Pediatr Res; 2008 Sep; 64(3):256-61. PubMed ID: 18437097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation action of N-acetylcysteine on the anticonvulsant effect of sodium valproate in mice.
    Devi PU; Pillai KK; Vohora D
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):521-2. PubMed ID: 16635113
    [No Abstract]   [Full Text] [Related]  

  • 5. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
    Lavoie S; Murray MM; Deppen P; Knyazeva MG; Berk M; Boulat O; Bovet P; Bush AI; Conus P; Copolov D; Fornari E; Meuli R; Solida A; Vianin P; Cuénod M; Buclin T; Do KQ
    Neuropsychopharmacology; 2008 Aug; 33(9):2187-99. PubMed ID: 18004285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine.
    Cabungcal JH; Steullet P; Kraftsik R; Cuenod M; Do KQ
    Biol Psychiatry; 2013 Mar; 73(6):574-82. PubMed ID: 23140664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N-acetylcysteine and cystine in glutathione synthesis in human erythrocytes.
    Whillier S; Raftos JE; Chapman B; Kuchel PW
    Redox Rep; 2009; 14(3):115-24. PubMed ID: 19490753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset senescence occurs when fibroblasts lack the glutamate-cysteine ligase modifier subunit.
    Chen Y; Johansson E; Fan Y; Shertzer HG; Vasiliou V; Nebert DW; Dalton TP
    Free Radic Biol Med; 2009 Aug; 47(4):410-8. PubMed ID: 19427898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant supplementation partially rescues accelerated ovarian follicle loss, but not oocyte quality, of glutathione-deficient mice†.
    Lim J; Ali S; Liao LS; Nguyen ES; Ortiz L; Reshel S; Luderer U
    Biol Reprod; 2020 Apr; 102(5):1065-1079. PubMed ID: 31950131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postresuscitation N-acetylcysteine treatment reduces cerebral hydrogen peroxide in the hypoxic piglet brain.
    Lee TF; Jantzie LL; Todd KG; Cheung PY
    Intensive Care Med; 2008 Jan; 34(1):190-7. PubMed ID: 17938888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene.
    Tosic M; Ott J; Barral S; Bovet P; Deppen P; Gheorghita F; Matthey ML; Parnas J; Preisig M; Saraga M; Solida A; Timm S; Wang AG; Werge T; Cuénod M; Do KQ
    Am J Hum Genet; 2006 Sep; 79(3):586-92. PubMed ID: 16909399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency.
    Atkuri KR; Mantovani JJ; Herzenberg LA; Herzenberg LA
    Curr Opin Pharmacol; 2007 Aug; 7(4):355-9. PubMed ID: 17602868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why.
    Aldini G; Altomare A; Baron G; Vistoli G; Carini M; Borsani L; Sergio F
    Free Radic Res; 2018 Jul; 52(7):751-762. PubMed ID: 29742938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of N-acetylcysteine.
    Kelly GS
    Altern Med Rev; 1998 Apr; 3(2):114-27. PubMed ID: 9577247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system.
    Rodrigues SD; França KC; Dallin FT; Fujihara CK; Nascimento AJ; Pecoits-Filho R; Nakao LS
    Life Sci; 2015 Jan; 121():110-6. PubMed ID: 25500303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine.
    Behr J; Degenkolb B; Krombach F; Vogelmeier C
    Eur Respir J; 2002 May; 19(5):906-11. PubMed ID: 12030732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early, transient increase in complexin I and complexin II in the cerebral cortex following traumatic brain injury is attenuated by N-acetylcysteine.
    Yi JH; Hoover R; McIntosh TK; Hazell AS
    J Neurotrauma; 2006 Jan; 23(1):86-96. PubMed ID: 16430375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.
    Zhang H; Limphong P; Pieper J; Liu Q; Rodesch CK; Christians E; Benjamin IJ
    FASEB J; 2012 Apr; 26(4):1442-51. PubMed ID: 22202674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochondrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats.
    Kamboj SS; Sandhir R
    Mitochondrion; 2011 Jan; 11(1):214-22. PubMed ID: 21059408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [N-Acetylcysteine: new possibilities to use an old substance].
    Ahola T; Lapatto R
    Duodecim; 1999; 115(4):375-9. PubMed ID: 11830885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.